Indication
Hemophagocytic lymphohistiocytosis
Hemophagocytic lymphohistiocytosis is a rare, life-threatening hyperinflammatory syndrome characterized by severe immune dysregulation and uncontrolled activation of cytotoxic T lymphocytes, natural killer cells, and macrophages. Read more about Hemophagocytic lymphohistiocytosis
2 drugs 2 manufacturers
Drugs that treat it
Common Hemophagocytic lymphohistiocytosis therapies.
GAMIFANT (emapalumab-lzsg)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonHemophagocytic lymphohistiocytosis is a rare, life-threatening hyperinflammatory syndrome characterized by severe immune dysregulation and uncontrolled activation of cytotoxic T lymphocytes, natural killer cells, and macrophages.
The condition can affect individuals of any age, presenting either as a primary inherited disorder typically emerging in infancy or early childhood, or as an acquired secondary syndrome in older children and adults triggered by severe infections, malignancies, or autoimmune diseases.
Pathophysiologically, the failure of normal cytotoxic down-regulation leads to hypercytokinemia, excessive tissue infiltration, and hemophagocytosis across the reticuloendothelial and hematologic systems.
Hallmark clinical features include persistent high fevers, hepatosplenomegaly, progressive cytopenias, marked hyperferritinemia, hypofibrinogenemia, and rapid progression toward multiorgan dysfunction.
- nih.gov
Hemophagocytic lymphohistiocytosis is a rare, life-threatening hyperinflammatory syndrome characterized by severe immune dysregulation and uncontrolled activation of cytotoxic T lymphocytes, natural killer cells, and macrophages Pathophysiologically, the failure of normal cytotoxic down-regulation leads to hypercytokinemia, excessive tissue infiltration, and hemophagocytosis across the reticuloendothelial and hematologic systems Hallmark clinical features include persistent high fevers, hepatosp...
- nih.gov
Hemophagocytic lymphohistiocytosis is a rare, life-threatening hyperinflammatory syndrome characterized by severe immune dysregulation and uncontrolled activation of cytotoxic T lymphocytes, natural killer cells, and macrophages The condition can affect individuals of any age, presenting either as a primary inherited disorder typically emerging in infancy or early childhood, or as an acquired secondary syndrome in older children and adults triggered by severe infections, malignancies, or autoimm...
- nih.gov
The condition can affect individuals of any age, presenting either as a primary inherited disorder typically emerging in infancy or early childhood, or as an acquired secondary syndrome in older children and adults triggered by severe infections, malignancies, or autoimmune diseases Hallmark clinical features include persistent high fevers, hepatosplenomegaly, progressive cytopenias, marked hyperferritinemia, hypofibrinogenemia, and rapid progression toward multiorgan dysfunction
- nih.gov
Pathophysiologically, the failure of normal cytotoxic down-regulation leads to hypercytokinemia, excessive tissue infiltration, and hemophagocytosis across the reticuloendothelial and hematologic systems
Personalize your experience
Follow Hemophagocytic lymphohistiocytosis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.